Extended SARS-CoV-2 RBD booster vaccination induces humoral and cellular immune tolerance in mice-Reference-Cited by-同舟云学术

Extended SARS-CoV-2 RBD booster vaccination induces humoral and cellular immune tolerance in mice

Published:2022-12 Issue:12 Volume:25 Page:105479
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Gao Feng-Xia,Wu Rui-Xin,Shen Mei-Ying,Huang Jing-Jing,Li Ting-Ting,Hu Chao,Luo Fei-Yang,Song Shu-Yi,Mu Song,Hao Ya-Nan,Han Xiao-Jian,Wang Ying-Ming,Li Luo,Li Sheng-Long,Chen Qian,Wang Wang,Jin Ai-Shun

Funder

Chongqing Medical University

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference29 articles.

1. Homologous and heterologous Covid-19 booster vaccinations;Atmar;N. Engl. J. Med.,2022

2. Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil;Cerqueira-Silva;Nat. Commun.,2022

3. Effectiveness of ChAdOx1 nCoV-19 vaccine during the delta (B.1.617.2) variant surge in India;Chakrabarti;Lancet Infect. Dis.,2022

4. Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination;Cheng;Nat. Med.,2022

5. Treg cell IL-10 and IL-35 exhaust CD8(+) T cells in tumors;Damo;Nat. Immunol.,2019

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heterologous booster vaccination enhances antibody responses to SARS-CoV-2 by improving Tfh function and increasing B-cell clonotype SHM frequency;Frontiers in Immunology;2024-06-21

2. Molecular mimicry of SARS-COV-2 antigens as a possible natural anti-cancer preventive immunization;Frontiers in Immunology;2024-06-14

3. Evaluation of antibody responses in healthy individuals receiving SARS-CoV-2 inactivated vaccines;Biosafety and Health;2024-06

4. Serum SARS-CoV-2 antibodies in HIV-1-infected patients after inactivated vaccination and SARS-CoV-2 infection;Heliyon;2024-06

5. Mutation Trajectory of Omicron SARS-CoV-2 Virus, Measured by Principal Component Analysis;COVID;2024-04-22